Cambridge, UK: We are extremely excited to announce that o2h Ventures has been shortlisted as a finalist at the Growth Investor Awards 22 for the ‘ Best EIS Manager – Specialist’ category.
The category acknowledges and celebrates outstanding investment managers in Enterprise Investment Schemes with a specialist focus on a particular area of underlying investments. The evaluation was based on assessing the success across business performance, investment inflows, impact on the investors, adviser relations, customer feedback, and overall impact.
The focus of o2h Ventures has always been to seek out biotech therapeutic opportunities within the UK and then support these ventures through investment and connection into the industry. We have worked diligently to curate a strong portfolio for both our funds SEIS and KI EIS. Check out our HMRC-approved KI EIS fund wherein we invest in research-focused biotech companies which is soon observing its close.
About the Growth Investor Awards 2022
Reflecting how far the industry has come in recent years, the Growth Investor Awards are bigger than ever this year. With 28 categories, and more than 80 opportunities to win an accolade. The awards will be celebrated with a gala dinner at the prestigious London Hilton Park Lane, on the evening of November 24th.
To Know More: Click here